Insider Transactions in Q1 2024 at Spero Therapeutics, Inc. (SPRO)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2024
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
45,093
-3.69%
|
$45,093
$1.45 P/Share
|
|
Feb 02
2024
|
Ankit Mahadevia |
SELL
Open market or private sale
|
Direct |
63,795
-7.89%
|
$63,795
$1.37 P/Share
|
|
Feb 02
2024
|
Timothy Keutzer Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,971
-5.48%
|
$30,971
$1.36 P/Share
|
|
Feb 02
2024
|
Kamal Hamed Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
28,075
-3.44%
|
$28,075
$1.37 P/Share
|
|
Feb 02
2024
|
Tamara L Joseph Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
30,906
-5.49%
|
$30,906
$1.37 P/Share
|
|
Feb 02
2024
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
30,901
-2.47%
|
$30,901
$1.37 P/Share
|
|
Feb 01
2024
|
Timothy Keutzer Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
239,731
+29.79%
|
-
|
|
Feb 01
2024
|
Kamal Hamed Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
239,731
+22.7%
|
-
|
|
Feb 01
2024
|
Tamara L Joseph Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
239,731
+29.88%
|
-
|
|
Feb 01
2024
|
Sath Shukla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
679,501
+35.18%
|
-
|
|
Feb 01
2024
|
Esther Rajavelu CFO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
119,866
+22.21%
|
-
|